Regis Healthcare Past Earnings Performance
Past criteria checks 0/6
Regis Healthcare's earnings have been declining at an average annual rate of -60.9%, while the Healthcare industry saw earnings declining at 3.3% annually. Revenues have been growing at an average rate of 7.4% per year.
Key information
-60.9%
Earnings growth rate
-60.9%
EPS growth rate
| Healthcare Industry Growth | 2.4% |
| Revenue growth rate | 7.4% |
| Return on equity | n/a |
| Net Margin | -2.1% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Regis Healthcare Limited's (ASX:REG) P/S Is Still On The Mark Following 31% Share Price Bounce
Sep 12
Is There An Opportunity With Regis Healthcare Limited's (ASX:REG) 38% Undervaluation?
May 02At AU$3.94, Is It Time To Put Regis Healthcare Limited (ASX:REG) On Your Watch List?
Mar 21Regis Healthcare (ASX:REG) Has Announced A Dividend Of A$0.0628
Feb 28Regis Healthcare Limited's (ASX:REG) CEO Compensation Looks Acceptable To Us And Here's Why
Oct 18Regis Healthcare (ASX:REG) Is Paying Out A Larger Dividend Than Last Year
Aug 29Regis Healthcare (ASX:REG) Is Paying Out Less In Dividends Than Last Year
Mar 01Is Regis Healthcare (ASX:REG) Using Debt Sensibly?
Oct 27Regis Healthcare's (ASX:REG) Shareholders Will Receive A Smaller Dividend Than Last Year
Aug 26Regis Healthcare Limited's (ASX:REG) Intrinsic Value Is Potentially 34% Above Its Share Price
Feb 25Is Regis Healthcare Limited (ASX:REG) Potentially Undervalued?
May 27Estimating The Fair Value Of Regis Healthcare Limited (ASX:REG)
May 09Should You Be Excited About Regis Healthcare Limited's (ASX:REG) 23% Return On Equity?
Aug 10At AU$1.32, Is Regis Healthcare Limited (ASX:REG) Worth Looking At Closely?
Aug 10Reflecting on Regis Healthcare's (ASX:REG) Share Price Returns Over The Last Five Years
Jul 14Is Regis Healthcare Limited (ASX:REG) An Attractive Dividend Stock?
Jul 02Revenue & Expenses Breakdown
How Regis Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 1,014 | -21 | 80 | 0 |
| 31 Mar 24 | 947 | -18 | 84 | 0 |
| 31 Dec 23 | 880 | -15 | 93 | 0 |
| 30 Sep 23 | 830 | -22 | 88 | 0 |
| 30 Jun 23 | 781 | -28 | 77 | 0 |
| 31 Mar 23 | 761 | -45 | 71 | 0 |
| 31 Dec 22 | 741 | -61 | 66 | 0 |
| 30 Sep 22 | 733 | -50 | 66 | 0 |
| 30 Jun 22 | 725 | -39 | 66 | 0 |
| 31 Mar 22 | 719 | -16 | 66 | 0 |
| 31 Dec 21 | 713 | 8 | 67 | 0 |
| 30 Sep 21 | 707 | 14 | 65 | 0 |
| 30 Jun 21 | 701 | 20 | 63 | 0 |
| 31 Mar 21 | 700 | 8 | 62 | 0 |
| 31 Dec 20 | 699 | -4 | 61 | 0 |
| 30 Sep 20 | 688 | -2 | 60 | 0 |
| 30 Jun 20 | 678 | -1 | 60 | 0 |
| 31 Mar 20 | 655 | 21 | 58 | 0 |
| 31 Dec 19 | 661 | 39 | 55 | 0 |
| 30 Sep 19 | 654 | 45 | 54 | 0 |
| 30 Jun 19 | 647 | 51 | 54 | 0 |
| 31 Mar 19 | 632 | 51 | 50 | 0 |
| 31 Dec 18 | 617 | 50 | 47 | 0 |
| 30 Sep 18 | 606 | 52 | 46 | 0 |
| 30 Jun 18 | 594 | 54 | 46 | 0 |
| 31 Mar 18 | 586 | 56 | 46 | 0 |
| 31 Dec 17 | 577 | 57 | 47 | 0 |
| 30 Sep 17 | 571 | 59 | 45 | 0 |
| 30 Jun 17 | 565 | 61 | 43 | 0 |
| 31 Mar 17 | 547 | 55 | 40 | 0 |
| 31 Dec 16 | 529 | 50 | 38 | 0 |
| 30 Sep 16 | 505 | 48 | 36 | 0 |
| 30 Jun 16 | 481 | 47 | 34 | 0 |
| 31 Mar 16 | 468 | 59 | 35 | 0 |
| 31 Dec 15 | 455 | 71 | 35 | 0 |
| 30 Sep 15 | 446 | 64 | 35 | 0 |
| 30 Jun 15 | 438 | 58 | 35 | 0 |
| 31 Mar 15 | 433 | 28 | 43 | 0 |
| 31 Dec 14 | 428 | -1 | 51 | 0 |
| 30 Sep 14 | 419 | 0 | 52 | 0 |
| 30 Jun 14 | 410 | 1 | 54 | 0 |
Quality Earnings: REG is currently unprofitable.
Growing Profit Margin: REG is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: REG is unprofitable, and losses have increased over the past 5 years at a rate of 60.9% per year.
Accelerating Growth: Unable to compare REG's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: REG is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-25.4%).
Return on Equity
High ROE: REG's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.